218 related articles for article (PubMed ID: 36619413)
1. Systems biology and
Hossain MA; Al Ashik SA; Mahin MR; Al Amin M; Rahman MH; Khan MA; Emran AA
Heliyon; 2022 Dec; 8(12):e12480. PubMed ID: 36619413
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics and In silico approaches to identify novel biomarkers and key pathways for cancers that are linked to the progression of female infertility: A comprehensive approach for drug discovery.
Hossain MA; Sohel M; Rahman MH; Hasan MI; Khan MS; Amin MA; Islam MZ; Peng S
PLoS One; 2023; 18(1):e0265746. PubMed ID: 36608061
[TBL] [Abstract][Full Text] [Related]
3. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
4. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome.
Chen Y; Ma L; Ge Z; Pan Y; Xie L
Front Mol Biosci; 2022; 9():888194. PubMed ID: 35693550
[No Abstract] [Full Text] [Related]
5. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.
Qiao G; Xing J; Luo X; Zhang C; Yi J
Endocrine; 2022 Dec; 78(3):615-627. PubMed ID: 36068422
[TBL] [Abstract][Full Text] [Related]
6. A Network-Based Bioinformatics Approach to Identify Molecular Biomarkers for Type 2 Diabetes that Are Linked to the Progression of Neurological Diseases.
Rahman MH; Peng S; Hu X; Chen C; Rahman MR; Uddin S; Quinn JMW; Moni MA
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32041280
[TBL] [Abstract][Full Text] [Related]
7. Exploration of hub genes involved in PCOS using biological informatics methods.
Zhou F; Xing Y; Cheng T; Yang L; Ma H
Medicine (Baltimore); 2022 Oct; 101(40):e30905. PubMed ID: 36221354
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic analysis identifies diagnostic genes in polycystic ovary syndrome and periodontitis.
Liu X; Zhang J; Wang X; Zhang Z
Eur J Med Res; 2024 Jan; 29(1):3. PubMed ID: 38167332
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.
Wei L; Xin C; Wang W; Hao C
Gene; 2018 Jun; 661():85-94. PubMed ID: 29601948
[TBL] [Abstract][Full Text] [Related]
10. Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development.
Liao B; Qi X; Yun C; Qiao J; Pang Y
Front Endocrinol (Lausanne); 2022; 13():815968. PubMed ID: 35237237
[TBL] [Abstract][Full Text] [Related]
11. Construction of a ceRNA network in polycystic ovary syndrome (PCOS) driven by exosomal lncRNA.
Bai L; Gong J; Guo Y; Li Y; Huang H; Liu X
Front Genet; 2022; 13():979924. PubMed ID: 36406137
[TBL] [Abstract][Full Text] [Related]
12. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
Yu J; Fu Y; Zeng L; Zheng Y
Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.
Chen H; Cheng S; Xiong W; Tan X
Ann Transl Med; 2021 Jul; 9(14):1156. PubMed ID: 34430597
[TBL] [Abstract][Full Text] [Related]
14. Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities.
Nayan SI; Rahman MH; Hasan MM; Raj SMRH; Almoyad MAA; Liò P; Moni MA
Life Sci; 2023 Dec; 335():122244. PubMed ID: 37949208
[TBL] [Abstract][Full Text] [Related]
15. Exploration of molecular features of PCOS with different androgen levels and immune-related prognostic biomarkers associated with implantation failure.
Gao Q; Ma C; Meng S; Wang G; Xing Q; Xu Y; He X; Wang T; Cao Y
Front Endocrinol (Lausanne); 2022; 13():946504. PubMed ID: 36060967
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.
Guan C; Zahid S; Minhas AS; Ouyang P; Vaught A; Baker VL; Michos ED
Fertil Steril; 2022 May; 117(5):924-935. PubMed ID: 35512976
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Biomarkers of Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis.
Yang D; Li N; Ma A; Dai F; Zheng Y; Hu X; Wang Y; Xian S; Zhang L; Yuan M; Liu S; Deng Z; Yang Y; Cheng Y
Reprod Sci; 2021 May; 28(5):1353-1361. PubMed ID: 33067753
[TBL] [Abstract][Full Text] [Related]
18. WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs.
Li M; Zeng Z; Zhang A; Ye Q; Su S; Xia T
Int J Gen Med; 2021; 14():8737-8751. PubMed ID: 34849014
[TBL] [Abstract][Full Text] [Related]
19. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
[TBL] [Abstract][Full Text] [Related]
20. Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules.
Prashanth G; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
BMC Endocr Disord; 2021 Apr; 21(1):80. PubMed ID: 33902539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]